Monitoring of cardiac graft recipients: comparison of in vivo activated, committed T lymphocytes in peripheral blood and in the graft.
The proliferative and cytotoxic capacity of peripheral blood lymphocytes (PBL) and the cytotoxic activity of lymphocytes propagated from endomyocardial biopsies (EMB) towards donor cells was used to identify in vivo activated, committed T cells. A series of 39 PBL samples and 38 EMB simultaneously taken from 20 patients after heart transplantation was cultured in interleukin 2 (IL-2) conditioned medium. The cytotoxic capacity of these cultures against donor cells was tested in a 4-h chromium-51 release assay. From a comparable patient group, 224 samples were evaluated for donor reactivity by a primed lymphocyte test (PLT). Analysis showed that PBL cultures hardly ever contained committed cytotoxic T lymphocytes (cCTL, 2/39) or committed proliferative T lymphocytes (cPTL, 1/224). In contrast, significantly more EMB cultures (17/38, P < 0.001, chi2 test) demonstrated donor-directed cytotoxicity. This was especially found during rejection (11/17 vs 6/21 without rejection, P = 0.05). These results show that after heart transplantation, committed cells are mainly found in the graft.
Baan
C C
CC
Department of Internal Medicine I, University Hospital Rotterdam-Dijkzigt, Rotterdam The Netherlands.
Vaessen
L M
LM
Ouwehand
A J
AJ
Heyse
P
P
Daane
C R
CR
Jutte
N H
NH
Claas
F H
FH
Weimar
W
W
D018929:Cell Culture Techniques; D003602:Cytotoxicity, Immunologic; D006084:Graft Rejection / Q000175:diagnosis / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D015166:Monitoring, Immunologic / Q000379:methods; D008991:Monitoring, Physiologic / Q000379:methods; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*